|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0100 CAD | 0.00% |
|
0.00% | -83.33% |
| Market Cap | 11.94L 8L 7L 7L 6L 8.11Cr 12.14L 81.95L 32.06L 4.01Cr 31.78L 31.09L 14Cr | P/E 2024 |
-0.07x | P/E 2025 | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 5L 3L 3L 3L 3L 3.2Cr 5L 32.29L 12.63L 1.58Cr 12.52L 12.25L 5.46Cr | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.32x |
| Free-Float |
68.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 month | -33.33% | ||
| 3 months | -33.33% | ||
| 6 months | -71.43% | ||
| Current year | -83.33% |
| 1 month | 0 | 0.01 | |
| Current year | 0 | 0.05 | |
| 1 year | 0 | 0.25 | |
| 3 years | 0 | 0.25 | |
| 5 years | 0 | 0.8 | |
| 10 years | 0 | 1.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
CEO | Chief Executive Officer | - | 01/10/2019 |
José Roldan
DFI | Director of Finance/CFO | - | 09/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
BRD | Director/Board Member | - | 01/10/2019 |
Daniel Augereau
BRD | Director/Board Member | 82 | 01/10/2019 |
Eric Klein
BRD | Director/Board Member | 66 | 01/10/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02/06/25 | Sell | Chief Executive Officer | 46,67,000 | 3.9091% | ||
| 21/03/25 | Buy | Chief Executive Officer | 2,00,000 | 0.1675% | ||
| 21/03/25 | Buy | Chief Executive Officer | 1,00,000 | 0.0838% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | 0.00% | -83.33% | 8L | ||
| +1.93% | +6.43% | +50.20% | +168.28% | 1,06800Cr | ||
| +0.29% | +7.20% | +58.48% | +53.57% | 64TCr | ||
| +2.45% | +3.88% | +38.32% | +76.82% | 45TCr | ||
| +2.17% | +10.91% | +41.94% | +35.03% | 35TCr | ||
| +1.46% | +5.93% | +40.44% | +43.69% | 30TCr | ||
| +0.40% | +4.52% | +19.79% | +20.93% | 27TCr | ||
| +2.73% | +2.26% | -25.81% | -36.98% | 22TCr | ||
| +4.48% | +7.94% | +28.22% | +66.53% | 20TCr | ||
| +2.91% | +0.83% | +15.59% | +75.56% | 16TCr | ||
| Average | +1.49% | +2.48% | +26.72% | +42.01% | 36.63TCr | |
| Weighted average by Cap. | +0.99% | +2.85% | +39.07% | +81.20% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 43.42L 30.76L 27.04L 25.21L 23.18L 29Cr 44.14L 2.98Cr 1.17Cr 15Cr 1.16Cr 1.13Cr 50Cr | 33.61L 23.81L 20.93L 19.51L 17.94L 23Cr 34.17L 2.31Cr 90.24L 11Cr 89.46L 87.52L 39Cr |
| Net income | -1.65Cr -1.17Cr -1.03Cr -95.81L -88.09L -112.09Cr -1.68Cr -11Cr -4.43Cr -55Cr -4.39Cr -4.3Cr -191.62Cr | -89.1L -63.13L -55.49L -51.73L -47.56L -61Cr -90.59L -6.12Cr -2.39Cr -30Cr -2.37Cr -2.32Cr -103.46Cr |
| Net Debt | -6L -4L -4L -4L -3L -4.25Cr -6L -42.95L -16.8L -2.1Cr -16.66L -16.3L -7.27Cr | -7L -5L -5L -4L -4L -4.91Cr -7L -49.66L -19.43L -2.43Cr -19.26L -18.84L -8.4Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- RAMM Stock
Select your edition
All financial news and data tailored to specific country editions
















